Marina Baretti, MD, is an assistant professor at Johns Hopkins University School of Medicine and the Jiasheng Chair in Hepato-Biliary Cancer Research. She also serves as Co-Director of the Liver and Biliary Cancer Multidisciplinary Clinic at the Sidney Kimmel Comprehensive Cancer Center (SKCCC). Dr. Baretti received her medical degree from the University of Pisa in Italy. She completed her internal medicine residency and oncology fellowship at University of Milan. She then went on and completed her Postdoctoral and Medical Oncology Fellowship at Johns Hopkins University, Baltimore, Maryland. She is deeply engaged in bridging the gap between laboratory discoveries and clinical application, working closely with laboratory-based scientists to accelerate the development of novel therapeutic strategies. Her academic research is centered on the development of novel agents in hepatobiliary cancers, with particular interest in combinatorial approaches of immunotherapies. She is currently the principal investigator on multiple clinical trials in FLC, HCC and cholangiocarcinoma at Johns Hopkins University, collaborating closely with laboratory-based researchers to move laboratory findings into patients. Through her work, Dr. Baretti strives to improve outcomes for patients with rare GI cancers by identifying innovative therapies that are informed by a deeper understanding of tumor biology and the tumor microenvironment. Dr. Baretti was the recipient of the 2018 American Society of Clinical Oncology Young Investigator Award. Dr. Baretti was also awarded with the 2020 Career Development Award for the MD Anderson Cancer Center’s pancreatic cancer NCI Specialized Programs of Research Excellence (SPORE). Dr. Baretti is rated as an Elite provider by MediFind in the treatment of Fibrolamellar Carcinoma. Her top areas of expertise are Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), Liver Cancer, and Pancreatic Cancer.

Dr. Mark Yarchoan is a physician–scientist based in Baltimore who specializes in the treatment and study of gastrointestinal cancers, with a particular focus on liver malignancies, including hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA). He received his undergraduate degree from Amherst College and his medical degree from the Perelman School of Medicine at the University of Pennsylvania. He completed his residency in internal medicine at the Hospital of the University of Pennsylvania, followed by a fellowship in medical oncology at the Johns Hopkins University School of Medicine, where he joined the faculty in 2018. Dr. Yarchoan leads a research laboratory dedicated to developing novel immunotherapies for liver cancers. His translational research program integrates analyses of clinical trial biospecimens with preclinical modeling to identify and overcome barriers to effective antitumor immunity. A major focus of his work is the development of therapeutic cancer vaccines for hepatobiliary malignancies. He serves as Principal Investigator on multiple clinical trials for hepatobiliary cancers, contributes to international guideline committees for liver cancer, and is a member of the Johns Hopkins Graduate Training Programs in Cellular and Molecular Medicine and Immunology. Dr. Yarchoan’s contributions have been recognized with numerous honors, including the ASCO Young Investigator Award, the Conquer Cancer Foundation Career Development Award, the Mark R. Clements Award from the Cholangiocarcinoma Foundation, and the Blue Faery Award for Excellence in Liver Cancer Research. Dr. Yarchoan is rated as an Elite provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), Liver Cancer, Pancreatic Cancer, and Hepatectomy.

Dr. Georgiades earned a series of degrees (BSc-Mechanical Engineering, MS & PhD-Radiological Sciences and an MD). He received a 1-year training in Internal Medicine at Harvard and subsequently, completed subspecialty training at Johns Hopkins in Diagnostic and Interventional Radiology. He has been a full time faculty at Johns Hopkins since 2003 (except for a 3 year hiatus 2012-2015 when he set up a private practice overseas). He has held various positions including fellowship director, clinical director and was a member of many Departmental and Institutional committees. He is a prolific researcher with more than 100 manuscripts, more than 100 abstracts, 28 book chapters and numerous presentations at national and international fora. Dr. Georgiades is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Fibrolamellar Carcinoma, Bile Duct Obstruction, Neuroendocrine Tumor, Liver Embolization, and Gastrostomy.

Dr. Kelvin K. Hong is an Associate Professor and Executive Vice Chair of Radiology within the Johns Hopkins Department of Radiology. A specialist in interventional and vascular radiology, Dr. Hong serves as the Medical Director of the Johns Hopkins Interventional Radiology Center. Dr. Hong earned his medical degree from South Africa’s University Of Witwatersrand Medical School in Parktown. He completed a radiology residency at Parktown West’s College of Medicine/Radiology, as well as a cardiovascular/interventional radiology fellowship and diagnostic radiology residency at The Johns Hopkins Hospital. His areas of clinical expertise include bone, liver and soft-tissue tumors; chronic total occlusions; claudication; deep venous thrombosis; lung, esophageal and kidney cancer; peripheral arterial/vascular disease; renal artery/vascular disease; uterine fibroid tumors; varicocele; and vascular malformations and venous thromboembolism. Dr. Hong performs procedures that include radiofrequency ablation for lung, liver, kidney and bone lesions; transcatheter arterial chemoembolization for liver cancer; lower-extremity angioplasty and stenting; visceral angioplasty and stenting; embolization of uterine fibroid tumors; cryoablation for pain control; and percutaneous laser ablation of varicose veins. Dr. Hong served as editor for the book Percutaneous Tumor Ablation and contributed to Interventional Oncology: Principles and Practice. Dr. Hong is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Fibrolamellar Carcinoma, Bile Duct Obstruction, Neuroendocrine Tumor, Liver Embolization, and Pancreaticoduodenectomy.

Elizabeth Jaffee is an Oncologist in Baltimore, Maryland. Dr. Jaffee is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. Her top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Fibrolamellar Carcinoma, Pancreaticoduodenectomy, and Hepato-Pancreato-Biliary Surgery.

Specializing in hepatology, Dr. Kim sees patients with chronic viral hepatitis, autoimmune liver diseases, fatty liver disease, abnormal liver enzymes, cirrhosis, portal hypertension, hepatocellular carcinoma and liver transplantation. She has research interests in liver lesions and hepatocellular carcinoma. Dr. Kim has been recognized with numerous awards and has authored several peer-reviewed publications in hepatology. Dr. Kim is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. Her top areas of expertise are Hepatitis, Fibrolamellar Carcinoma, Macroamylasemia, and Visceromegaly.

Dr. Daniel Laheru is a cancer specialist in Baltimore, caring for patients with pancreatic cancer, colorectal cancer and neuroendocrine cancers. Dr. Laheru serves as co-director of the Skip Viragh Center for Pancreas Cancer Clinical Research and Patient Care at Johns Hopkins Medicine. Dr. Laheru received his undergraduate degree in chemistry from The University of Utah. He earned his M.D. at Baylor College of Medicine. He completed his residency at The University of Utah Hospital and Clinics and performed a fellowship in medical oncology at The Johns Hopkins University School of Medicine and The Johns Hopkins Oncology Center. Dr. Laheru joined the Johns Hopkins faculty in 2001. Dr. Laheru's research interests include pancreatic cancer and chemotherapy resistance in pancreatic cancer. With Elizabeth Jaffee, M.D., he developed a vaccine that supercharges the immune system and causes immune cells, which tend to be tolerant of cancer, to seek out and kill pancreatic cancer cells throughout the body. He has given numerous invited talks on pancreatic cancer and other cancers both nationally and internationally. He has authored over 200 papers focused on pancreatic cancer. Dr. Laheru serves as associate editor of Annals of Pancreatic Cancer. He has been recognized by the American Society of Clinical Oncology with the Young Investigator Award, by the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins as an Isaac and Catharine Hecht Scholar and has been elected to the Miller-Coulson Academy of Clinical Excellence. He is a member of the American College of Physicians, the American Society of Clinical Oncology and the American Association for Cancer Research. Dr. Laheru is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy.

Dr. Gurakar joined Johns Hopkins from the Nazih Zuhdi Transplantation Institute at the Integris Baptist Medical Center in Oklahoma City, where he was the chief of Hepatology Research and the program director of the Liver Transplantation Medicine/ Hepatology Fellowship. He served at various capacities in the Liver Medicine Section, since its first establishment in 1993. Dr. Gurakar's clinical interests include pre and post-transplant, clinical and endoscopic management of liver diseases and viral hepatitis. His research interests include bioartificial liver dialysis systems and application of total plasma exchange in the treatment of liver disorders. Dr. Gurakar is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Hepatitis, Liver Failure, Alcoholic Cirrhosis, Liver Transplant, and Kidney Transplant.

Dr. Won Jin Ho is a physician-scientist at Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins who focuses on cancer immunology and tumor microenvironment research. Dr. Ho received his BS and MS in Biomedical Engineering from University of California, Los Angeles, and his MD from Wayne State University School of Medicine. Dr. Ho completed a research track internal medicine residency as an NIH F32 postdoctoral fellow at Case Western Reserve University and subsequently completed a medical oncology fellowship at Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins as the recipient of ASCO Young Investigator Award and AACR Immuno-Oncology Fellowship. Dr. Ho's overarching research interest is to develop novel immunotherapeutic strategies even against immune-resistant cancers by first understanding the immune responses to current therapeutics. Dr. Ho focuses on determining the systemic and in situ changes by leveraging cutting-edge technologies. With his expertise in mass cytometry, Dr. Ho is co-leading many of the systemic and spatial immune profiling efforts at Johns Hopkins. Dr. Ho also is developing novel small-molecule cancer therapeutics and methodologies for translational discovery. Dr. Ho is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Fibrolamellar Carcinoma, Liver Cancer, and Hepato-Pancreato-Biliary Surgery.

Dr. Brian G. Johnson is the chief of interventional radiology at Sibley Memorial Hospital. Dr. Johnson practices out of Sibley Memorial Hospital in Washington, D.C., Suburban Hospital in Bethesda, MD and the Johns Hopkins Hospital in Baltimore, MD. Dr. Johnson graduated summa cum laude from University of Minnesota prior to earning his medical degree from Johns Hopkins University School of Medicine. He completed a residency in physical medicine and rehabilitation at Sinai Hospital of Baltimore, as well as a residency in diagnostic radiology at the University of Maryland Medical Center. Dr. Johnson also completed an interventional radiology fellowship at Johns Hopkins University. Dr. Johnson has been repeatedly named a Top Doctor by Washingtonian Magazine, as well as a Top MD by Consumers' Checkbook Magazine. He is a member of the American College of Radiology and the Society of Interventional Radiology. Videos Brian Johnson, M.D.Interventional Radiology Selected Publications Neuromodulatory effect of the atrial natriuretic factor clearance receptor binding peptide, cANF(4-23)-NH2 in the rabbit isolated vas deferentia, Johnson BG, Trachte GJ, Drewett JG, J Pharm & Exp Ther - 1/1/1991 Percutaneous Management of Renal and Renal-Pancreas Transplant Recipients Using CT Fluoroscopy: A Two Year Experience. Krebs TL, Johnson BG, Daly BD, Wong-You-Chong JJ, Bartlett ST, Radiological Society of North America Meeting, Chicago, IL - 1/29/1998 The hexagonal cell nitinol intravascular stent: a comparison of the effects of varying the stent wire gauge on the aorta and inferior vena cava in the swine animal model. Kuo J, Johnson BG, Venbrux AC, Olson JL, Samphilipo MA, Magee CA, Kobelja MA, Anderson JH, Osterman FA, American Roentgen Ray Society Annual Meeting, New Orleans, LA - 1/24/1994 The role of anticoagulation in the setting of a tethered vena cava filter in the swine animal model. Johnson BG, Reichle RL, Venbrux AC, Samphilipo MA, Magee CA, Anderson JH, Osterman FA, Society for Cardiovascular and Interventional Radiology Annual Meeting, Fort Lauderdale, FL - 1/1/1995. Dr. Johnson is rated as an Advanced provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Bile Duct Obstruction, Vertebroplasty, and Bone Graft.

Debashish Bose is a Surgical Oncologist and a General Surgeon in Baltimore, Maryland. Dr. Bose is rated as an Experienced provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Pancreatic Pseudocyst, Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection. Dr. Bose is currently accepting new patients.

Md Siddiqui is a Hematologist Oncology specialist and a Hematologist in Salisbury, Maryland. Dr. Siddiqui is rated as an Experienced provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Pulmonary Embolism, Inflammatory Breast Cancer, Angiosarcoma, and Childhood Iron Deficiency Anemia. Dr. Siddiqui is currently accepting new patients.

Solomon Levin is a General Surgeon in Baltimore, Maryland. Dr. Levin is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Fibrolamellar Carcinoma and Liver Cancer.

Alexander Kim is an Interventional Radiologist and a Radiologist in Oxon Hill, Maryland. Dr. Kim is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Fibrolamellar Carcinoma, Visceromegaly, Familial Pancreatic Cancer, Liver Embolization, and Prostatic Artery Embolization. Dr. Kim is currently accepting new patients.

Hyun Kim is an Interventional Radiologist and a Radiologist in Baltimore, Maryland. Dr. Kim is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Fibrolamellar Carcinoma, Liver Cancer, Cholangiocarcinoma (Bile Duct Cancer), Liver Embolization, and Gastrostomy.

Nabeel Akhter is an Interventional Radiologist and a Radiologist in Baltimore, Maryland. Dr. Akhter is rated as a Distinguished provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Fibrolamellar Carcinoma, Visceromegaly, Colorectal Cancer, Gastrostomy, and Liver Embolization.

Ana De Jesus is an Oncologist in Baltimore, Maryland. Dr. De Jesus is rated as an Experienced provider by MediFind in the treatment of Fibrolamellar Carcinoma. Her top areas of expertise are Pancreatic Cancer, Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Pancreaticoduodenectomy, and Pancreatectomy.

Dr. Bhagat is an interventional radiologist serving as the director of Vascular and Interventional Radiology of the National Capital Region. His primary areas of clinical expertise are interventional oncology (chemoembolization, radioembolization, and ablation), women's interventions, and vascular interventions (venous and arterial). Dr. Bhagat sees patients at both Suburban Hospital and Sibley Memorial Hospital. His research interests include interventional oncology, especially device development and software assistance for complex procedures. Dr. Bhagat successfully completed his Vascular and Interventional Radiology fellowship at the University of California, San Francisco in 2009. He joined the staff as an Assistant Professor of Radiology and Surgery at the Johns Hopkins University School of Medicine. While there, he authored more than 5 book chapters and 20 peer-reviewed manuscripts as well as giving many lectures at national and international meetings. In his second year at Johns Hopkins, he received a NIH R01 grant. Videos Nikhil Bhagat, M.D. Dr. Bhagat is rated as an Experienced provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Ascites, Familial Pancreatic Cancer, Small Cell Lung Cancer (SCLC), Liver Embolization, and Gastrostomy.

Dr. Homeira Zahiri is a Clinical Associate in the Johns Hopkins Medicine Department of Radiology and Radiological Science. She received her medical degree from Islamic Azad University - Tehran Branch. She performed residencies at Tehran University of Medical Sciences in pathology, University of Nebraska Medical Center in nuclear medicine and Creighton University School of Medicine in radiology. Dr. Zahiri completed a body imaging fellowship at Johns Hopkins Medicine. Dr. Zahiri is rated as an Experienced provider by MediFind in the treatment of Fibrolamellar Carcinoma. Her top areas of expertise are Pleurisy, Pleural Effusion, ALK-Positive Non-Small Cell Lung Cancer, and Visceromegaly.

Dr. Sedaghat graduated from the University of Virginia in 2006 and the Johns Hopkins University School of Medicine in 2010. He completed an internal medicine internship at GBMC in 2011 and a radiology residency at Geisinger Medical Center in Pennsylvania in 2015. Dr. Sedaghat also completed a 2-year fellowship in abdominal imaging and intervention at Brigham and Women’s Hospital in Boston from 2015-2017. He is Ultrasound Section Chief in the department of radiology. Dr. Sedaghat is rated as an Experienced provider by MediFind in the treatment of Fibrolamellar Carcinoma. His top areas of expertise are Ascites, Ampullary Cancer, Lymphofollicular Hyperplasia, and Thyroid Nodule.